Risk of Juvenile Idiopathic Arthritis Following HPV9 Vaccination: A Retrospective Cohort Study Before and During the COVID-19 Pandemic
The HPV9 vaccination was associated with a lower risk of JIA, and this effect can last at least for 3 years. The COVID-19 pandemic did not alter this relationship. These findings reinforce the immunological safety of HPV9 and provide reassurance for adolescent vaccination programs, even in pandemic contexts.
Authors
- Hsin‐Hua Chen (ORCID: https://orcid.org/0000-0002-7304-4587)
- Ming-Chin Tsai (ORCID: https://orcid.org/0000-0002-7206-4228)
- Lin‐Shien Fu
- Yung‐Chieh Huang (ORCID: https://orcid.org/0000-0003-2945-4404)
- Chiann‐Yi Hsu
- Wenyu Wu (ORCID: https://orcid.org/0000-0001-9365-684X)
Institutions
- National Chung Hsing University (TW)
- Taichung Veterans General Hospital (TW)
Publication Details
- Journal
- Mayo Clinic Proceedings Innovations Quality & Outcomes
- Published
- 2025-09-09
- DOI
- https://doi.org/10.1016/j.mayocpiqo.2025.100647
- Primary Topic
- Cervical Cancer and HPV Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Taichung Veterans General Hospital